EntryPoint Capital’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-8,738
| Closed | -$249K | – | 841 |
|
|
2024
Q3 | $249K | Buy |
8,738
+8,268
| +1,759% | +$236K | 0.14% | 340 |
|
|
2024
Q2 | $12.4K | Sell |
470
-2,442
| -84% | -$64.5K | 0.02% | 746 |
|
|
2024
Q1 | $94.1K | Buy |
2,912
+2,163
| +289% | +$69.9K | 0.08% | 464 |
|
|
2023
Q4 | $31.6K | Buy |
+749
| New | +$31.6K | 0.03% | 905 |
|